EKF Diagnostics (LON:EKF) Stock Price Crosses Below Two Hundred Day Moving Average – What’s Next?

Shares of EKF Diagnostics Holdings plc (LON:EKF) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 25.66 and traded as low as GBX 25.30. EKF Diagnostics shares last traded at GBX 25.41, with a volume of 99,145 shares trading hands.

Analysts Set New Price Targets

Separately, Stifel Nicolaus restated a “buy” rating and set a GBX 35 price target on shares of EKF Diagnostics in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, EKF Diagnostics presently has an average rating of “Buy” and a consensus target price of GBX 35.

EKF Diagnostics Stock Performance

The stock has a fifty day simple moving average of GBX 26.26 and a two-hundred day simple moving average of GBX 25.66. The firm has a market capitalization of £109.32 million, a P/E ratio of 54.06 and a beta of 0.51. The company has a debt-to-equity ratio of 2.01, a current ratio of 4.16 and a quick ratio of 1.77.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.